Velleca Mark A.

CIK 00017068472 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001706847

Recent Transactions

50 trades

Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2026-01-21+600,000→ 600,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2025-01-30+500,000→ 500,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-01-30+75,000→ 121,522 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2024-02-14+537,000→ 537,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2023-09-17+1,000,000→ 1,000,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2023-09-15$3.60/sh+5,208→ 46,522 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2023-08-08−57,286→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2023-08-08$0.30/sh+2,714→ 118,714 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-08-08$2.02/sh−2,714→ 116,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2023-08-08−2,714→ 242,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2023-08-08$0.39/sh+57,286→ 173,286 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-08-08$2.00/sh−57,286→ 116,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2023-06-16$2.10/sh+8,929→ 41,314 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2023-05-16+16,500→ 16,500 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2023-03-16$1.67/sh+11,228→ 32,385 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-12-16$1.50/sh+8,424→ 21,157 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-10-18$11.70/sh−15,000→ 116,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-18−15,000→ 57,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-10-18$0.39/sh+15,000→ 131,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-20−20,000→ 72,286 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-09-20$13.50/sh−20,000→ 116,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-09-20$0.39/sh+20,000→ 136,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-09-16$2.62/sh+4,294→ 12,733 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-08-16$12.64/sh−80,000→ 116,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2022-08-16−80,000→ 92,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-08-16$0.39/sh+80,000→ 196,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-06-17$2.03/sh+5,542→ 8,439 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2022-06-10+15,000→ 15,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-03-18$3.02/sh+2,897→ 2,897 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2022-02-07−15,000→ 172,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2022-02-07$0.39/sh+15,000→ 116,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-11-09−40,000→ 187,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-11-09$0.39/sh+40,000→ 101,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-08-09+30,000→ 30,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-07-15−10,000→ 227,286 total
Sale
G1 Therapeutics, Inc.
Common Stock
2021-07-15$18.49/sh−10,000→ 61,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-07-15$0.39/sh+10,000→ 71,000 total
Sale
G1 Therapeutics, Inc.
Common Stock
2021-07-14$19.08/sh−10,000→ 61,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-07-14$0.39/sh+10,000→ 71,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-07-14−10,000→ 237,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-07-13−10,000→ 247,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-07-13$0.39/sh+10,000→ 71,000 total
Sale
G1 Therapeutics, Inc.
Common Stock
2021-07-13$19.45/sh−10,000→ 61,000 total
Sale
G1 Therapeutics, Inc.
Common Stock
2021-06-17$21.77/sh−10,000→ 61,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-06-17−10,000→ 257,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-06-17$0.39/sh+10,000→ 71,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-06-16−10,000→ 267,286 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-06-16$0.39/sh+10,000→ 71,000 total
Sale
G1 Therapeutics, Inc.
Common Stock
2021-06-16$21.74/sh−10,000→ 61,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2021-06-15$0.39/sh+10,000→ 71,000 total

Companies

Recent Filings

Address

C/O BLACK DIAMOND THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov